1373 SynBAd, a clinical cancer vaccine candidate, induces antigen-specific T cells and extends life in a therapeutic liver cancer model

• Shahrooz Rabizadeh,
• Kayvan R Niazi,
• Peter A Sieling,
• Steve Benz,
• Justin Golovato,
• Aleece Nolasco

Affiliations

Shahrooz Rabizadeh

ImmunityBio, Inc, Culver City, California, USA

Kayvan R Niazi

Sagittarius Bio, Inc., Thousand Oaks, CA, USA

Peter A Sieling

Sagittarius Bio, Inc., Thousand Oaks, CA, USA

Steve Benz

Sagittarius Bio, Inc., Thousand Oaks, CA, USA

Justin Golovato

Sagittarius Bio, Inc., Thousand Oaks, CA, USA

Aleece Nolasco

Sagittarius Bio, Inc., Thousand Oaks, CA, USA